Developmental shedding and regrowth of neuronal cilia
Active Grant Awarded
- Award ID
- RNS148227UM1RY3
- Recipient
-
The Children's Hospital Corporation UEI Z1L9F1MM1RY3
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $672,047
Award facts
- Assistance listing
- 93.NS1 Neurosciences and Neurological Disorders – Research Projects (RP)
- Completion date 0% complete
- Place of performance
- Boston, MA 02115, USA
Award details come from USAspending.gov.
About this award
The Department of Health and Human Services National Institutes of Health National Institute of Neurological Disorders and Stroke awarded The Children's Hospital Corporation, doing business as Boston Children's Hospital, a grant obligating $672,047 on November 19, 2026, under the Neurosciences and Neurological Disorders – Research Projects (RP) program (CFDA 93.NS1). The ultimate completion date is November 30, 2031, and place of performance is Boston, Massachusetts 02115.
The funded project uses C. elegans to investigate developmental shedding and regrowth of neuronal cilia, a property the project describes as previously overlooked. Preliminary data show that specific C. elegans sensory neurons shed more than 80% of their cilia length at developmentally regulated molts. The project identifies two candidate regulators of cilia shedding. The first, MAM-5, is a secreted extracellular matrix protein that glia produce transiently at the time of shedding and that causes severe cilia morphology defects when disrupted. The stated objective is to identify molecular mechanisms of neuronal cilia shedding.
The program supports extramural research funded by NINDS, including basic research on the fundamental structure and function of the brain and nervous system.
Description
- Abstract
- Primary cilia are key controllers of cellular development and, when disrupted, lead to developmental disorders called ciliopathies. Many ciliopathies include neurodevelopmental changes ranging from structural brain anomalies to intellectual disability and autism, pointing to important and understudied roles for neuronal cilia in the brain. Indeed, a recent series of electronic microscopy (EM) studies revealed remarkable overlooked properties of neuronal cilia, including participating in synapses and mediating neuron-glia interactions, highlighting the need to better understand fundamental properties of neuronal cilia in vivo. This project uses C. Elegans to investigate a novel property of neuronal cilia: developmental shedding and regrowth. Cilia shedding has been studied in the context of motile cilia as a stress response, and occurs in a developmentally regulated manner in photoreceptors that shed the distal 10% of their cilia in response to circadian cues. By contrast, our preliminary data show that specific C. Elegans sensory neurons shed >80% of their cilia length at developmentally regulated molts. Developmentally controlled cilia shedding may thus represent yet another overlooked feature of neuronal cilia: IT would allow these long-lived cells to renew aging or damaged cilia, and would represent a potent mechanism to reset signaling pathways in response to changes in organismal physiology or to break cilia-synapse or cilia- glia connections and form new ones. As most features of cilia are highly conserved, C. Elegans offers a powerful genetic system to identify molecular mechanisms of neuronal cilia shedding. Preliminary data point to two candidates as regulators of cilia shedding. MAM-5 is a secreted ECM protein produced by glia transiently at the time of cilia shedding, localizes to cilia precisely at the site of shedding, and causes severe cilia morphology defects when disrupted, which together suggest a role in cilia shedding. CAT-6 is a doublecortin-like kinase we identified that is expressed only during molts by the neurons that shed their cilia and localizes to cilia. Loss of CAT-6 does not affect embryonic cilia development, but results in severely truncated cilia following the first molt, suggesting a defect in cilia regrowth after shedding. This project will (aim 1) determine how glial-secreted MAM-5 affects cilia morphogenesis, (aim 2) identify CAT-6 kinase targets and interacting partners to explain its function during cilia shedding and regrowth, and (aim 3) use candidate-based and unbiased genetic screens to identify novel regulators of neuronal cilia shedding.
Quick answers
Who received award RNS148227UM1RY3?
RNS148227UM1RY3 was awarded to The Children's Hospital Corporation by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on November 19, 2026.
How much is award RNS148227UM1RY3 worth?
$672,047 has been obligated on RNS148227UM1RY3.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award